Miromatrix Medical (NASDAQ:MIRO – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Volatility & Risk Miromatrix Medical has a […]
Perkins Capital Management Inc. acquired a new stake in Miromatrix Medical Inc. (NASDAQ:MIRO – Free Report) during the 1st quarter, Holdings Channel reports. The firm acquired 151,320 shares of the company’s stock, valued at approximately $254,000. Several other large investors have also made changes to their positions in the business. Gagnon Securities LLC lifted its […]
Miromatrix Medical (NASDAQ:MIRO – Get Free Report) is scheduled to release its earnings data after the market closes on Monday, August 14th. Analysts expect Miromatrix Medical to post earnings of ($0.32) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. Miromatrix Medical (NASDAQ:MIRO […]
Miromatrix Medical (NASDAQ:MIRO – Get Rating) had its target price trimmed by Piper Sandler from $6.00 to $3.00 in a research note published on Friday, The Fly reports. Miromatrix Medical Stock Performance Shares of MIRO opened at $1.12 on Friday. The company has a current ratio of 5.52, a quick ratio of 5.52 and a […]